← Back to Search

Treatment for Heart Failure (INTERPRET Trial)

N/A
Waitlist Available
Research Sponsored by Coram Clinical Trials
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, on average 6 months
Awards & highlights

Summary

The INTERPRET Inotrope Evaluation and Research Patient Registry is a longitudinal, observational study designed to look at the demographics and outcomes of heart failure patients on inotropic therapy administered in the home or infusion suite setting. The data gathered in this registry will provide information on how a patient's quality of life and symptoms change over time while on inotrope therapy, and help healthcare providers to have a better understanding of the benefits and risks associated with bridge-to-treatment and palliative care.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, on average 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, on average 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Duration of re-hospitalizations
Implantable cardioverter defibrillator (ICD) activity
Mean time of survival post-treatment
+4 more
Secondary study objectives
Additional patient symptoms
Concomitant medication use

Find a Location

Who is running the clinical trial?

Coram Clinical TrialsLead Sponsor
3 Previous Clinical Trials
2,316 Total Patients Enrolled
Columbia UniversityOTHER
1,471 Previous Clinical Trials
2,536,221 Total Patients Enrolled
20 Trials studying Heart Failure
6,061 Patients Enrolled for Heart Failure
Northwestern UniversityOTHER
1,625 Previous Clinical Trials
937,160 Total Patients Enrolled
22 Trials studying Heart Failure
6,554 Patients Enrolled for Heart Failure
~12 spots leftby Sep 2025